Although a slight numerical improvement in PFS time was noted in group 1 compared with group 2, it did not reach statistical significance (P>0.05; Fig. 6 ).
← all excerpts
Efficacy of transarterial chemoembolization-hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy in hepatocellular carcinoma with portal vein tumor thrombosis.
1
0.0500
0.0500